Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society

The role of eHealth, telehealth, and telemedicine for chronic disease patients during COVID-19 pandemic: A rapid systematic review

“…Most of the articles used the term telemedicine (n ¼ 17; 68%) to describe the used technology or recommended to use in providing healthcare services needed for chronic disease patients. [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] Fifteen articles used the term telehealth (53.8%), [15][16][17][27][28][29][30][31][32][33][34][35][36][37][38] while two articles used the term eHealth (7.7%). 18,32 However, some of these articles used more than one term (e.g., 17 ).…”

“…37 Three articles focused on chronic diseases in general. 14,21,25 The types of paper were varied including six review paper, 22,23,28,32,35,37 three articles, 13,14,36 four expert opinions, 18,19,27,34 two viewpoints, 24,26 one brief correspondence, 21 one commentary, 33 one position statement, 31 one feasibility study, 15 one perspective, opinion, and commentary, 20 one clinical practice statement, 29 one research letter, 16 one short survey, 17 one quantitative study, 30 and one mini review. 25 Tables 1 to 3 detail the current status of the use and implementation of eHealth, telemedicine, and/or telehealth technologies to manage chronic disease patients during the COVID-19 pandemic as well as the main findings and/or recommendations regarding the use of eHealth, telemedicine, and/or telehealth technologies in providing care to patients living with chronic disease/condition during the pandemic.…”

Thromboprophylaxis in hospitalized COVID-19 patients: the efficacy and safety of the approved hospital protocol

“…Thromboembolic complications are serious COVID-19 manifestations which often lead to life-threatening condition [22][23][24][25][26]. A meta-analyses covering articles published to June 2020, demonstrated that the overall VTE rate among COVID-19 patients was 9%-21%, with 5% among non-ICU and 21-31% among ICU patients [27,28].…”

Point of Care Ultrasound During the Covid-19 Pandemic Should Screen for Inter-Atrial Shunt

“…These reviews are particularly important as other specialist societies suggest that formal ultrasound and echocardiography performed by sonographers and radiologists should be limited [3]. Guidance on management of structural heart disease [4,5] during the Covid-19 pandemic must be considered. These recommendations suggest that closure of inter-atrial defects (i.e.…”

“…These recommendations suggest that closure of inter-atrial defects (i.e. patent foramen ovale [PFO] and atrial septal defects [ASD]) should be deferred [4,5].…”